The United States Continuous Glucose Monitoring (CGM) market size is expected to surpass USD 5 billion by 2027.
“United States Continuous Glucose Monitoring (CGM) Market Report” is based on an inclusive study of the entire United States Continuous Glucose Monitoring (CGM) market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States Continuous Glucose Monitoring (CGM) market. The study also presents a comprehensive analysis of the market dynamics and estimation of the market size over the forecast period 2021 – 2027. The report delivers a clear understanding of the up-to-date and future growths of the United States Continuous Glucose Monitoring (CGM) market.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues for Continuous Glucose Monitoring (CGM), and an illustrative forecast for 2027. The report also provides an all-around analysis of the overall number of patients with diabetes and insulin users in the United States. An all-inclusive examination has been done on the pricing, demand, and key development of the Continuous Glucose Monitoring (CGM) market in the United States. The report also reveals facts, statistics, growth rate, and demand of the Continuous Glucose Monitoring (CGM) Vs Blood Glucose Meter (BGM) market in the United States. A comprehensive comparative analysis has been done on Continuous Glucose Monitoring Devices.
Additionally, this up-to-date report describes the latest features reimbursement pattern and offers a clear view of the regulatory framework of the United States Continuous Glucose Monitoring (CGM) market. Key trends in terms of collaboration and partnership deals are analysed in detail. The report also delivers an in-depth analysis of evolving market trends, drivers, and restraining forces that influence the growth of the market.
The report also analyses detailed profiles of innovative and leading players with information on business overview, product portfolio, and the latest developments. Other emerging players are making novel technology-based Continuous Glucose Monitoring (CGM) that are likely to affect the market share during the forecast period.
This Comprehensive Market Research Report Provides:
• To Analyse the Historical Growth in the Market Size of the United States Continuous Glucose Monitoring (CGM) Market from 2019 to 2020
• To Estimate and Forecast the Market Size of the United States Continuous Glucose Monitoring (CGM) from 2021 to 2027 and Growth Rate until 2027
• Detailed Assessment of the United States Continuous Glucose Monitoring (CGM) Users Volume and Forecast to 2027
• Thoroughly Assessment of the United States Continuous Glucose Monitoring (CGM) Vs Blood Glucose Meter (BGM) Market Size and Growth Rate (2019 – 2027)
• Delivers Comprehensive Insights on the Continuous Glucose Monitoring Devices Comparative Analysis
• An Insightful Analysis of the United States Diabetes Population and Forecast to 2027
• Delivers a Complete Overview of the United States Insulin Users and Forecast to 2027
• Detailed Insights into the Regulatory Framework of the United States Continuous Glucose Monitoring (CGM) Market
• Features Reimbursement Patterns of the United States Continuous Glucose Monitoring (CGM) Market
• Delivers an In-Depth Analysis of Evolving Market Trends, Drivers and Restraints of the United States Continuous Glucose Monitoring (CGM) Market
• Tracks Competitive Developments, Approaches, Recent Industry Developments, Collaboration Deals, and Partnership Deals
• A Comprehensive List of the Key Players Along with the Analysis of their Current Product Portfolios, Business Overview, and Recent Development
The Leading Companies for the United States Continuous Glucose Monitoring (CGM) Market are Listed Below:
• Abbott
• Dexcom, Inc.
• Medtronic, Inc.
• Senseonics Holdings, Inc.
Key Questions Addressed by the Report
• What is the current size of the overall Continuous Glucose Monitoring (CGM) market in the United States?
• How much will this market be worth from 2021 to 2027?
• How big is the United States CGM market?
• How much do continuous glucose monitors cost?
• What is the key marketed Continuous Glucose Monitoring (CGM) devices available in the United States?
• What are the major drivers of the United States Continuous Glucose Monitoring (CGM) market?
• What are the major inhibitors of the United States Continuous Glucose Monitoring (CGM) market?
• What is the reimbursement pattern in the United States Continuous Glucose Monitoring (CGM) market?
• What is the regulatory framework in the United States Continuous Glucose Monitoring (CGM) market?
• Which companies make continuous glucose monitors?
• Who are the top market players? What are their happenings, current developments, and scenarios?
• How is the market predicted to develop in the future?
'
1. Executive Summary
2. United States Diabetes Population (2019 – 2027): An Analysis
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes
3. United States Insulin Users and Forecast (2019 – 2027)
4. United States Continuous Glucose Monitoring (CGM) Users Volume Assessment and Market Size 2019 –2027
4.1 Continuous Glucose Monitoring (CGM) Users Volume Assessment
4.2 Continuous Glucose Monitoring (CGM) Market Size and Forecast
5. United States Continuous Glucose Monitoring (CGM) Vs Blood Glucose Meter (BGM) Market Size and Growth Rate (2019 – 2027)
6. United States Continuous Glucose Monitoring Market Growth Drivers and Challenges
6.1 Key Market Growth Drivers
6.2 Key Market Challenges
7. Continuous Glucose Monitoring Devices Comparative Analysis
8. Reimbursement Environment of the United States Continuous Glucose Monitoring Market
9. Regulation Framework of the United States Continuous Glucose Monitoring Market
10. Collaboration Deals in the Continuous Glucose Monitoring Market
11. Partnership Deals in the Continuous Glucose Monitoring Market
12. Key Companies Analysis
12.1 Abbott
12.1.1 Business Overview
12.1.2 Product Portfolio
12.1.3 Recent Development
12.2 Dexcom, Inc.
12.2.1 Business Overview
12.2.2 Product Portfolio
12.2.3 Recent Development
12.3 Medtronic, Inc.
12.3.1 Business Overview
12.3.2 Product Portfolio
12.3.3 Recent Development
12.4 Senseonics Holdings, Inc.
12.4.1 Business Overview
12.4.2 Product Portfolio
12.4.3 Recent Development
List of Tables:
Table 5–1: United States BGM Vs CGM Market Size and Growth Rate
List of Figures:
Figure 2–1: United States Overall Diabetes Population (Thousand), 2019 – 2020
Figure 2–2: United States Overall Diabetes Population Forecast (Thousand), 2021 – 2027
Figure 2–3: United States Type 1 Diabetes Population Forecast (Thousand), 2019 – 2020
Figure 2–4: United States Type 1 Diabetes Population Forecast (Thousand), 2021 – 2027
Figure 2–5: United States Type 2 Diabetes Population (Thousand), 2019 – 2020
Figure 2–6: United States Type 2 Diabetes Population Forecast (Thousand), 2021 – 2027
Figure 2–7: United States Newly Diagnosed Type 1 Diabetes Population (Number), 2019 – 2020
Figure 2–8: United States Newly Diagnosed Type 1 Diabetes Population Forecast (Number), 2021 – 2027
Figure 3–1: United States Insulin Users (Thousand),2019 – 2020
Figure 3–2: United States Insulin Users Forecast (Thousand),2021 – 2027
Figure 4–1: United States Continuous Glucose Monitoring (CGM) Users (Thousand), 2019 – 2020
Figure 4–2: United States Continuous Glucose Monitoring (CGM) Users Forecast (Thousand), 2021 – 2027
Figure 4–3: United States Continuous Glucose Monitoring (CGM) Market (Million US$), 2019 – 2020
Figure 4–4: United States Continuous Glucose Monitoring (CGM) Market Forecast (Million US$), 2021 – 2027
Figure 5–1: United States BGM and CGM Growth Rate Line Graph
